Tirzepatide | 99% Purity | 10mg 15mg 20mg 60mg Vials | Lyophilized Powder | Shipped from China

Sales Manager: Lena
WhatsApp: +44 7547 930159
Email: 97925439lena@gmail.com

We are a peptide manufacturer with our own research laboratory and production line. We are committed to producing high quality research grade peptides of exceptional purity and consistency. We ensure strict quality control at every stage. The production process of lyophilized powder is mainly based on vacuum freeze-drying. Vacuum freeze-drying is used to maximize the activity and stability of the active ingredient, and the entire process from preparation to freeze-drying is carried out in our manufacturing facility, ensuring strict quality control, purity and consistency of each batch. Our commitment to excellence extends from the initial stages of peptide synthesis to packaging and delivery. We implement stringent quality control measures at every step to ensure that our products reach our customers in the purest, most consistent form.
Explore our range of products today and enhance your research

Tirzepatide is the world’s first GLP1/GIP dual receptor agonist developed by Eli Lilly and Company. It exhibits potent glucoselowering effects and significant weight reduction, represen ting a breakthrough in the treatment of type 2 diabetes and obesity.It improves glucose control by enhancing glucosedependent secretion, suppressing inappropriately elevated glucagon secretion, and delaying gastric emptying. It also reduces food intake and body weight through central effects on appetite and satiety.

Tirzepatide demonstrates a significantly greater reduction in HbA1c than semaglutide, SGLT2 inhibitors, and metformin. The 15 mg group achieves an average weight loss of 15%–22.5%, with a more pronou nced reduction in visceral fat. GIP mediates bidirectional regulation of glucagon, resulting in a lower risk of hypoglycemia during weight loss in nondiabetic patients. Tirzepatide also improves blood lipids, blood pressure, and fatty liver, and provides potential betacell protection.

These products are active pharmaceutical ingredients (APIs), not finished pharmaceutical products.

This product is for research and laboratory use only.

The buyer must fully comply with all applicable laws and regulations regarding the handling and use of this material.

1. Ultra-high purity: Each batch of product undergoes synthesis and purification, achieving a purity of over 99% (HPLC), ensuring reliable and reproducible results in sensitive experiments.

2. Precise dosage and consistency: Our peptide products are precisely weighed and vacuum-sealed under aseptic conditions. We strictly control batch-to-batch consistency.

3. Endotoxin-free and aseptic processing: Our peptides are produced in a cleanroom environment, free from endotoxins, microbial contamination, and other impurities that could interfere with cellular or in vivo studies.